AzTrials
AzTrials

Identity PathologyTFP-ANCT00571571

Application and Evaluation of Transference Focused Psychotherapy Modified for Adolescents

A study testing Psychotherapy and Individual Psychotherapy in people with Identity Pathology and Behavior Problems, run by Weill Medical College of Cornell University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Normal adolescence requires a successful resolution of identity crisis, which results in the development of satisfying relationships, success in school/work pursuits, and achievement of personal goals. Adolescents, who do not resolve this crisis, are at high risk for problems in those areas of functioning. Read more about this study

Who is it for?
Ages 14 to 21 years, women only
Conditions the study is for
Identity Pathology, Behavior Problems
What is being tested?
Psychotherapy and Individual Psychotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
Oct 2007to Dec 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 21 years
  • Women only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Female Adolescents, ages 14-21
  • A score of five out of nine critical items on the Borderline Personality Disorder Dimension Interview Scale.
  • Have interpersonal difficulties in school, family, and/or peer functioning.
  • Live at home with family.
  • Willingness to attend evaluation sessions and weekly, individual therapy.

Who cannot join

  • The presence of psychosis, substance dependence, non-verbal learning disability, antisocial behavior, and/or primary diagnoses of eating disorder, bipolar disorder, and obsessive-compulsive disorder.
  • The need for hospitalization for symptom management.
  • Significant cognitive impairment (Full Scale IQ <85).
  • The presence of a life-threatening medical illness.

Trial locations and contacts

1 site in 1 country.

Anna E Odom, Ph.D. contact

914-997-5946

ano9021@med.cornell.edu

Pamela A Foelsch, Ph.D. contact

212-213-9879

United States1 site, 1 recruiting
  • New York-Presbyterian Hospital

    White Plains, New York, 10605

    Maura L Lehr, LCSW, 914-997-5866, mll9001@nyp.org

    Anna E Odom, Ph.D.

    Recruiting

Other trials in United States

About this study

Normal adolescence requires a successful resolution of identity crisis, which results in the development of satisfying relationships, success in school/work pursuits, and achievement of personal goals. Adolescents, who do not resolve this crisis, are at high risk for problems in those areas of functioning. Transference Focused Psychotherapy for Adolescents (TFP-A) is a treatment that specifically addresses these issues, permitting adolescents to develop satisfying friendships, more appropriate interactions with authority, and achieve realistic life goals.

This study will evaluate the application of TFP-A, (a empirically validated treatment for adults with identity disturbance), to adolescents exhibiting the same behavioral and identity pathology. Subjects will be females; ages 14-21, with behaviors associated with identity problems, interpersonal difficulties with teachers, parents and/or peers, and live with their families. These adolescents will be randomly assigned to one of two treatment cells, TFP-A or Treatment as Usual (TAU). Subjects in TFP-A will receive weekly individual therapy for six months. The TAU group will receive standard individual therapy in the Outpatient Department. Both will receive medication as necessary. All subjects will participate in initial, weekly, and bi-monthly assessments during the six-month treatment period, and participate in a naturalistic follow-up study for an additional six months.

Read more

Hypothesis:

Adolescents with identity problems as seen in interpersonal, school, and/or family difficulties in the Transference Focused Psychotherapy for Adolescents (TFP-A) group will reduce these problem behaviors and improve management of their feelings and moods compared to adolescents with identity problems in the treatment as usual control group (TAU).

Being tested
Psychotherapy, Individual Psychotherapy
Keywords
Identity difussion, Adolescent psychotherapy, Transference Focused Psychotherapy for Adolescents, Identity, Identity crisis, Identity pathology
Medical subject headings
Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PsychotherapyBehavioural

    Also called TFP-A, Transference Focused Psychotherapy for Adolescents

    Individual psychotherapy with parent collateral/psychoeducation as necessary.

  • Individual PsychotherapyBehavioural

    Individual psychotherapy and family interventions (as needed)

Study groups in NCT00571571
Study groupRoleWhat they receive
TFP-AExperimentalSpecific aspects of TFP-A involve the setting up of a treatment contract/collaboration between patient and therapist to deal with the likely threats both to the treatment and to the patient's well being that may occur in the course of the treatment. After the behavioral symptoms of identity pathology are contained through structure and limit setting, the psychological structure that is believed to be the core of identity pathology are analyzed. In particular, treatment would involve the family in setting up the contract parameters, provide a psychoeducational component to the family and patient, inclusion of school personnel as appropriate to reinforce contract parameters, place an emphasis on the technique of clarification to understand specific emotional states.
Receives: Behavioral: Psychotherapy
ControlActive comparatorThe Control Group is treatment as usual in the outpatient clinic. Treatment in this arm will be carried out by therapists in the Outpatient Department. Treatment will be determined by the therapist(s) and carried out according to their particular orientation and their assessment of patient's needs. It is expected based on clinic data that the majority of patients will be seen at least one time per week.
Receives: Behavioral: Individual Psychotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reduction in interpersonal difficulties with parents, teachers, and/or peers. Improved management of their feelings and moods. Reduction in other problems behaviors (i.e. substance use, self-injurious behaviors)

    Measured: Subjects will be assessed at entry, 2 month, 4 months, 6 months, 8 months 10 months, and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Dec 2007 (estimated)
  2. Study startOct 2007
  3. Primary completionDec 2009 (estimated)
  4. Study completionDec 2009 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00571571
Sponsor's protocol ID
0610008834
Acronym
TFP-A
Status last verified
Jan 2011
First submitted
11 Dec 2007
Last updated
4 Jan 2011
Results posted
No
Data monitoring committee
No

Publications

  • Clarkin JF, Foelsch PA, Levy KN, Hull JW, Delaney JC, Kernberg OF. The development of a psychodynamic treatment for patients with borderline personality disorder: a preliminary study of behavioral change. J Pers Disord. 2001 Dec;15(6):487-95. doi: 10.1521/pedi.15.6.487.19190.

    PubMed 11778390
  • Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF. Evaluating three treatments for borderline personality disorder: a multiwave study. Am J Psychiatry. 2007 Jun;164(6):922-8. doi: 10.1176/ajp.2007.164.6.922.

    PubMed 17541052
  • Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF. The Personality Disorders Institute/Borderline Personality Disorder Research Foundation randomized control trial for borderline personality disorder: rationale, methods, and patient characteristics. J Pers Disord. 2004 Feb;18(1):52-72. doi: 10.1521/pedi.18.1.52.32769.

    PubMed 15061344

Questions about this trial

What is this clinical trial studying?

A study testing Psychotherapy and Individual Psychotherapy in people with Identity Pathology and Behavior Problems, run by Weill Medical College of Cornell University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Jan 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Anna E Odom, Ph.D. (914-997-5946, ano9021@med.cornell.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reduction in interpersonal difficulties with parents, teachers, and/or peers. Improved management of their feelings and moods. Reduction in other problems behaviors (i.e. substance use, self-injurious behaviors) (time frame: Subjects will be assessed at entry, 2 month, 4 months, 6 months, 8 months 10 months, and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00571571, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jan 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in